Fujian Wanchen Biotechnology Co. Ltd (300972) — Cash Flow-to-Debt Ratio
Fujian Wanchen Biotechnology Co. Ltd (300972) has a Cash Flow-to-Debt Ratio of 0.48x as of December 2025, meaning its operating cash flow of CN¥3.63 Billion could theoretically repay 0% of its total liabilities (CN¥7.50 Billion) in one year. See 300972 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Fujian Wanchen Biotechnology Co. Ltd Cash Flow-to-Debt Ratio (2019–2025)
Historical debt coverage capacity for Fujian Wanchen Biotechnology Co. Ltd across 7 annual periods. Also explore Fujian Wanchen Biotechnology Co. Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Fujian Wanchen Biotechnology Co. Ltd (2019–2025)
Year-by-year debt coverage analysis for Fujian Wanchen Biotechnology Co. Ltd. For market capitalisation and broader financial context, see 300972 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.48x | CN¥3.63 Billion | CN¥7.50 Billion | ▲ +230.7% |
| 2024 | 0.15x | CN¥848.35 Million | CN¥5.79 Billion | ▼ -53.8% |
| 2023 | 0.32x | CN¥1.02 Billion | CN¥3.23 Billion | ▲ +138.0% |
| 2022 | 0.13x | CN¥70.38 Million | CN¥528.79 Million | ▼ -71.7% |
| 2021 | 0.47x | CN¥98.82 Million | CN¥210.47 Million | ▼ -22.5% |
| 2020 | 0.61x | CN¥156.24 Million | CN¥257.94 Million | ▲ +6.2% |
| 2019 | 0.57x | CN¥177.28 Million | CN¥310.81 Million | — |